CRA experts advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint venture with Novartis on consumer health, and Novartis’s sale of Novartis Animal Health to Eli Lilly & Co. The deals ultimately went forward with certain divestitures.
AI in Health Care: Case Law and Enforcement Trends
Their discussion explores pressing issues surrounding artificial intelligence in healthcare, including antitrust concerns, patient-facing applications, claims...